MX2017002203A - Selectividad eficaz de proteinas recombinantes. - Google Patents
Selectividad eficaz de proteinas recombinantes.Info
- Publication number
- MX2017002203A MX2017002203A MX2017002203A MX2017002203A MX2017002203A MX 2017002203 A MX2017002203 A MX 2017002203A MX 2017002203 A MX2017002203 A MX 2017002203A MX 2017002203 A MX2017002203 A MX 2017002203A MX 2017002203 A MX2017002203 A MX 2017002203A
- Authority
- MX
- Mexico
- Prior art keywords
- expression
- recombinant proteins
- mammalian
- invention includes
- gpt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La invención proporciona un nuevo sistema de expresión que comprende un marcador de selección de mamífero que promueve modificaciones postraduccionales convenientes de las glicoproteínas. En particular, la invención incluye métodos y composiciones para la expresión óptima de proteínas recombinantes en células de mamíferos mediante el empleo de un sistema con marcador de selección basado en genes de GPT de origen mamífero. La invención incluye métodos que facilitan la selectividad y aumentan las copias de expresión así como el rendimiento de proteínas recombinantes en células de mamíferos, y métodos para el uso de los sistemas de expresión de GPT.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462039416P | 2014-08-19 | 2014-08-19 | |
PCT/US2015/045793 WO2016028838A1 (en) | 2014-08-19 | 2015-08-19 | Efficient selectivity of recombinant proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017002203A true MX2017002203A (es) | 2017-05-22 |
Family
ID=55347784
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017002203A MX2017002203A (es) | 2014-08-19 | 2015-08-19 | Selectividad eficaz de proteinas recombinantes. |
MX2021009154A MX2021009154A (es) | 2014-08-19 | 2017-02-17 | Selectividad eficaz de proteinas recombinantes. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021009154A MX2021009154A (es) | 2014-08-19 | 2017-02-17 | Selectividad eficaz de proteinas recombinantes. |
Country Status (27)
Country | Link |
---|---|
US (4) | US9732357B2 (es) |
EP (2) | EP3183359B1 (es) |
JP (3) | JP7115851B2 (es) |
KR (2) | KR102406976B1 (es) |
CN (2) | CN107075549B (es) |
AR (1) | AR102333A1 (es) |
AU (3) | AU2015305565B9 (es) |
BR (1) | BR112017003074A2 (es) |
CA (1) | CA2957036A1 (es) |
CY (1) | CY1124079T1 (es) |
DK (1) | DK3183359T3 (es) |
EA (1) | EA035340B1 (es) |
ES (1) | ES2849728T3 (es) |
HR (1) | HRP20210301T1 (es) |
HU (1) | HUE054069T2 (es) |
IL (3) | IL287020B (es) |
LT (1) | LT3183359T (es) |
MA (1) | MA40371B1 (es) |
MX (2) | MX2017002203A (es) |
MY (1) | MY191745A (es) |
PL (1) | PL3183359T3 (es) |
PT (1) | PT3183359T (es) |
RS (1) | RS61371B1 (es) |
SG (2) | SG10201707859RA (es) |
SI (1) | SI3183359T1 (es) |
TW (3) | TWI719945B (es) |
WO (1) | WO2016028838A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
CN111712566A (zh) * | 2018-02-08 | 2020-09-25 | 应用干细胞有限公司 | 用于筛选靶基因变体的方法 |
WO2021079909A1 (ja) | 2019-10-23 | 2021-04-29 | キヤノン株式会社 | セラミックス物品の製造方法およびセラミックス物品 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
US6281005B1 (en) | 1999-05-14 | 2001-08-28 | Copernicus Therapeutics, Inc. | Automated nucleic acid compaction device |
EP1392859B1 (en) | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
EP1492874B1 (en) | 2002-03-29 | 2011-01-19 | XOMA Technology Ltd. | Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
JP2005027599A (ja) * | 2003-07-09 | 2005-02-03 | Nara Institute Of Science & Technology | 植物由来遺伝子を用いた遺伝子導入植物の選抜法 |
EP1586585A1 (de) * | 2004-04-14 | 2005-10-19 | F. Hoffmann-La Roche Ag | Expressionssystem zur Herstellung von IL-15/Fc-Fusionsproteinen und ihre Verwendung |
PL2610334T3 (pl) | 2006-12-07 | 2017-05-31 | Dow Agrosciences Llc | Nowe geny markerów selekcyjnych |
PL2150617T3 (pl) | 2007-06-04 | 2015-04-30 | Regeneron Pharma | Wzmocniona ekspresja i regiony stabilności |
KR100927803B1 (ko) * | 2007-11-23 | 2009-11-23 | 한국생명공학연구원 | 식물 형질전환체를 선별하기 위한 마커로서 gpt 유전자 |
PT2796466T (pt) * | 2007-12-07 | 2018-02-23 | Zymogenetics Inc | Moléculas de anticorpo humanizado específicas para il-31 |
CA2722423A1 (en) * | 2008-04-22 | 2009-10-29 | Rutgers, The State University | Hcv e2 construct compositions and methods |
CN102307993B (zh) * | 2008-12-09 | 2014-06-25 | 哈洛齐梅公司 | 延长的可溶性ph20多肽及其用途 |
EP2674495A1 (en) | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
AR102333A1 (es) * | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
-
2015
- 2015-08-14 AR ARP150102631A patent/AR102333A1/es unknown
- 2015-08-17 TW TW104126657A patent/TWI719945B/zh active
- 2015-08-17 TW TW110101888A patent/TWI777374B/zh active
- 2015-08-17 TW TW111129504A patent/TWI832364B/zh active
- 2015-08-19 DK DK15833421.9T patent/DK3183359T3/da active
- 2015-08-19 JP JP2017509733A patent/JP7115851B2/ja active Active
- 2015-08-19 ES ES15833421T patent/ES2849728T3/es active Active
- 2015-08-19 MY MYPI2017700248A patent/MY191745A/en unknown
- 2015-08-19 AU AU2015305565A patent/AU2015305565B9/en active Active
- 2015-08-19 MX MX2017002203A patent/MX2017002203A/es unknown
- 2015-08-19 EA EA201790241A patent/EA035340B1/ru unknown
- 2015-08-19 US US14/829,834 patent/US9732357B2/en active Active
- 2015-08-19 CN CN201580044100.7A patent/CN107075549B/zh active Active
- 2015-08-19 LT LTEP15833421.9T patent/LT3183359T/lt unknown
- 2015-08-19 KR KR1020177006620A patent/KR102406976B1/ko active IP Right Grant
- 2015-08-19 CN CN202110402963.4A patent/CN113293139A/zh active Pending
- 2015-08-19 KR KR1020227018877A patent/KR102556383B1/ko active IP Right Grant
- 2015-08-19 SI SI201531487T patent/SI3183359T1/sl unknown
- 2015-08-19 IL IL287020A patent/IL287020B/en unknown
- 2015-08-19 WO PCT/US2015/045793 patent/WO2016028838A1/en active Application Filing
- 2015-08-19 PL PL15833421T patent/PL3183359T3/pl unknown
- 2015-08-19 PT PT158334219T patent/PT3183359T/pt unknown
- 2015-08-19 EP EP15833421.9A patent/EP3183359B1/en active Active
- 2015-08-19 RS RS20210103A patent/RS61371B1/sr unknown
- 2015-08-19 HU HUE15833421A patent/HUE054069T2/hu unknown
- 2015-08-19 EP EP20211902.0A patent/EP3901274A1/en active Pending
- 2015-08-19 SG SG10201707859RA patent/SG10201707859RA/en unknown
- 2015-08-19 MA MA40371A patent/MA40371B1/fr unknown
- 2015-08-19 SG SG11201701121UA patent/SG11201701121UA/en unknown
- 2015-08-19 CA CA2957036A patent/CA2957036A1/en active Pending
- 2015-08-19 BR BR112017003074-8A patent/BR112017003074A2/pt active Search and Examination
-
2017
- 2017-02-09 IL IL250531A patent/IL250531B/en unknown
- 2017-02-17 MX MX2021009154A patent/MX2021009154A/es unknown
- 2017-07-31 US US15/664,444 patent/US10457959B2/en active Active
-
2019
- 2019-09-10 US US16/566,253 patent/US11085053B2/en active Active
-
2020
- 2020-07-17 AU AU2020205336A patent/AU2020205336B2/en active Active
- 2020-08-05 JP JP2020132874A patent/JP7260510B2/ja active Active
-
2021
- 2021-02-08 CY CY20211100104T patent/CY1124079T1/el unknown
- 2021-02-23 HR HRP20210301TT patent/HRP20210301T1/hr unknown
- 2021-07-02 US US17/366,239 patent/US20210340564A1/en active Pending
-
2022
- 2022-08-04 IL IL295361A patent/IL295361B2/en unknown
-
2023
- 2023-02-10 AU AU2023200752A patent/AU2023200752B2/en active Active
- 2023-04-06 JP JP2023061971A patent/JP2023076667A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202201361B (en) | Methods and compositions comprising purified recombinant polypeptides | |
PH12018501280A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
MX2023001834A (es) | Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso. | |
PH12017500858A1 (en) | Mocrocyclic peptides useful as immunomodulators | |
MX2018008344A (es) | Proteinas quimericas y metodos para regular la expresion genica. | |
MX2017006127A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
MX2017003847A (es) | Proteinas biespecificas activables por proteasas. | |
PH12017500022A1 (en) | Carrier-antibody compositions and methods of making and using the same | |
MX2017009538A (es) | Antigenos de citomegalovirus y su uso. | |
EA201692025A1 (ru) | Доставка белков, осуществляемая на основе бактерий | |
MY183189A (en) | Non-human animals having a humanized a proliferation-inducing ligand gene | |
CY1124079T1 (el) | Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων | |
MX2015014424A (es) | Construcciones de proteinas mitocondriales y sus usos. | |
PH12016501689B1 (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
MX2020012356A (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. | |
EA201791918A1 (ru) | Модификация белков клеток-хозяев | |
MX2019013124A (es) | Proteinas de fusion de inhibidor de tripsina urinaria (uti). | |
EA201790360A1 (ru) | Получение полностью процессированного и функционального фактора x в фурин-секретирующей системе экспрессии млекопитающего | |
MX2018003445A (es) | Expresion de proteinas que contienen fc. |